GW Pharmaceuticals tests epilepsy drug in man as FDA softens stance

A.B. | ShareCast | 18 Sep, 2013 11:09 - Updated: 11:59 | | |


Cannabis-derived drug developer GW Pharmaceuticals has begun human trials of its epilepsy treatment.

The AIM- and Nasdaq-listed company said the novel drug candidate, currently named GWP42006, was one of its most promising and looked to have significantly fewer side effects than currently approved anti-epileptic drugs.

Dr. Stephen Wright, Director of Research and Development at the company said advancing GWP42006 to a first dose in man was a significant milestone in the development of this candidate.

“The decision to progress into Phase 1 follows several years of highly promising pre-clinical research," he added.

"We believe that GWP42006 has the potential to become an important advance in the treatment of epilepsy, a condition for which there remains a substantial unmet medical need."

Research with the Reading School of Pharmacy in Buckinghamshire has shown that GWP42006 not only exerts significant ability to treat seizures in a wide range of preclinical models of seizure and epilepsy, but is also better tolerated by patients compared to existing anti-epileptic drugs.

The company has been encouraged by recent interest in its products in the US. That arose after the pharmaceutical regulator, the Food and Drug Administration [FDA], allowed US epilepsy specialists and patient organizations to carry out treatment on a small number of pediatric epilepsy patients with a cannabidiol [CBD] formulation supplied by GW. These activities may generate initial evidence to add CBD as a further pipeline candidate for clinical evaluation in epilepsy.

Recent third quarter showed net cash of $66.3m thanks to a US IPO in May that raised $30.4m.

Shares in GWP were up 1.4% to 72p at 11:12 on Wednesday.


More news

16:19 Wednesday preview: Market microscope on MPC minutes and Fed update

Wednesday sees the posting of the minutes from the latest meeting of the Bank of England's Monterary Policy Committee and the latest statement from the US Federal Reserve also due for release.

16:14 Petrofac chief financial officer acquires 20,000 shares

Tim Weller, the chief financial officer of Petrofac, has acquired 20,000 shares in the oil and gas group.

16:10 Helius Energy fizzles lower as Avonmouth partner walks away

Helius Energy lost a quarter of its market value on Tuesday after the renewable electricity company revealed that its partner at the 100MW Avonmouth project has walked away.

16:06 Berkeley Group's finance director leaves with immediate effect

Berkeley Group's finance director (FD), Nick Simpkin, has left the board with immediate effect.

15:52 FTSE 250 movers: Ophir climbs after unveiling new gas discovery

Africa-focused Ophir Energy rose after it announced a new gas discovery in block R which it says increases the value of its 80%-owned offshore Equatorial Guinea project. The Silenus East-1 well found a 67m gross gas column in the primary target with a high-quality reservoir in line with pre-drill expectations.

15:24 Uber wins overturn in Geman ban

Car hire and pick-up service Uber has won a court ruling that reverses a national ban in Germany.

15:21 Airbus to streamline defence and space division

French aerospace giant Airbus Group will sell off certain non-core businesses as it streamlines its defence and space division in the face of tight government budgets and increasing global competition.

15:17 Sector movers: ASOS, N Brown drag retail stocks lower

A profit warning from online fashion group ASOS and an underwhelming statement from sector peer N Brown ensured that UK-listed retail stocks were firmly in negative territory on Tuesday.

15:12 G20 governments support OECD measure to fight corporate tax avoidance

Governments belonging to the G20 have given their support to a range of new, tougher rules in a bid to tackle the problem of corporate tax avoidance.

15:04 US open: Markets open lower as US PPI falls flat

Markets opened lower on Tuesday, as investors remained cautious ahead of the Federal Open Market Committee’s two-day policy meeting.



Scotland's independence would be a painful divorce, says Cameron

Prime Minister David Cameron on Monday called Scotland's potential separation from the UK a "painful divorce".


The first resistance level now changes from 1.3220 to 1.3160